1. |
|
|
2. |
- Johnell, Olof, et al.
(author)
-
Osteoporos
- 2004
-
In: Kropp och genus i medicinen. - 914403217X ; , s. 219-219
-
Book chapter (pop. science, debate, etc.)
|
|
3. |
|
|
4. |
- Troost, Frederik, et al.
(author)
-
Modulation of human microsomal triglyceride transfer protein (MTP or MTTP) gene expression by food-grade/ingested dietary microorganisms
- 2008
-
Patent (pop. science, debate, etc.)abstract
- The present invention relates to the field of using microorganisms, especially food grade bacteria, to modulate intestinal MTP expression levels in order to treat and/or prevent weight gain, obesity, atherosclerosis, hyperglyceridaemia, hyper- cholesterolaemia, diabetes, dyslipidaemia and/or disorders associated with impaired intestinal immune response to antigens.
|
|
5. |
|
|
6. |
- Meidute, Sandra, et al.
(author)
-
Palmitate-induced beta-cell dysfunction is associated with excessive NO pro-duction and is reversed by thiazolidinedione-mediated inhibition of GPR40 transduction mechanisms
- 2008
-
In: PLoS ONE. - : Public Library of Science (PLoS). ; 3:5
-
Journal article (pop. science, debate, etc.)abstract
- Background: Type 2 diabetes often displays hyperlipidemia. We examined palmitate effects on pancreatic islet function in relation to FFA receptor GPR40, NO generation, insulin release, and the PPARgama agonistic thiazolidinedione, rosiglitazone. Principal findings: Rosiglitazone suppressed acute palmitate-stimulated GPR40-transduced PI hydrolysis in HEK293 cells and insulin release from MIN6c cells and mouse islets. Culturing islets 24 h with palmitate at 5 mmol/l glucose induced beta-cell iNOS expression as revealed by confocal microscopy and in-creased the activities of ncNOS and iNOS associated with suppression of glucose-stimulated insulin response. Rosiglitazone reversed these effects. The expression of iNOS after high-glucose culturing was unaffected by rosiglitazone. Downregulation of GPR40 by antisense treatment abrogated GPR40 expression and suppressed palmitate-induced iNOS activity and insulin release. Conclusion: We conclude that, in addition to mediating acute FFA-stimulated insulin release, GPR40 is an important regulator of iNOS expression and dysfunctional insulin release during long-term exposure to FFA. The adverse effects of palmitate were counteracted by rosiglitazone at GPR40, suggesting that thiazolidinediones are beneficial for beta-cell function in hyperlipidemic type 2 diabetes.
|
|
7. |
- Booth, Shirley, et al.
(author)
-
Lärande via nätet - oberoende av tid och plats
- 2005
-
In: Lärande hela livet : en antologi om lärandets betydelse för utveckling i arbetsliv och samhälle. - 9144044305 ; , s. 203-203
-
Book chapter (pop. science, debate, etc.)
|
|
8. |
|
|
9. |
|
|
10. |
|
|